Posted by Michael Wonder on 14 Feb 2021
Does NICE influence the adoption and uptake of generics in the UK?
14 February 2021 - The aim of this paper is to examine generic competition in the UK, with a special focus on the role of health technology assessment on generic market entry and diffusion.
In the UK, where no direct price regulation on pharmaceuticals exists, health technology assessment has a leading role for recommending the use of medicines providing a non-regulatory aspect that may influence the dynamics in the generic market.
The paper focuses on the role of Technology Appraisals issued by NICE.
